 |
| The First Word | Top |
 |
 |
 |
Blues p531 Douglas K. McCormick doi:10.1038/nbt0593-531 PDF
(114K)
|
 |
| Correspondence | Top |
 |
 |
 |
Headline Outrage p532 Margaret D. Rosa doi:10.1038/nbt0593-532a PDF
(88K)
|
 |
 |
 |
Elephants in the Living Room p532 William F. Schraeder doi:10.1038/nbt0593-532b PDF
(88K)
|
 |
 |
 |
Pasteur's Place p532 Alfred Hemming doi:10.1038/nbt0593-532c PDF
(88K)
|
 |
 |
 |
Agbio Not the Problem p532 Peter Marketos doi:10.1038/nbt0593-532d PDF
(88K)
|
 |
 |
 |
Anniversary Greetings p532 David L. Poole doi:10.1038/nbt0593-532e PDF
(88K)
|
 |
 |
 |
| Errata |
 |
 |
 |
Errata p532 doi:10.1038/nbt0593-532f PDF
(88K)
|
 |
| Commentary | Top |
 |
 |
 |
The Strange Case of the Pitter p535 Bernard Dixon doi:10.1038/nbt0593-535 PDF
(108K)
|
 |
| News Analysis | Top |
 |
 |
 |
Clinton seeks $4.3 billion for biotech R&D p536 Jeffrey L. Fox doi:10.1038/nbt0593-536 PDF
(105K)
|
 |
 |
 |
FDA advisory panel okays beta interferon for MS pp538 - 539 Jeffrey L. Fox doi:10.1038/nbt0593-538 PDF
(237K)
|
 |
 |
 |
Centocor's CentoRx benefits risky angioplasty p539 B. J. Spalding doi:10.1038/nbt0593-539 PDF
(122K)
|
 |
 |
 |
Does Gensia's Arasine help heart patients? p541 B. J. Spalding doi:10.1038/nbt0593-541 PDF
(128K)
|
 |
 |
 |
Firms should pursue narrow indications p542 Paul Abrams doi:10.1038/nbt0593-542 PDF
(134K)
|
 |
 |
 |
Drug price controls will stunt biotech's growth pp544 - 545 Jeffrey Casdin doi:10.1038/nbt0593-544 PDF
(228K)
|
 |
 |
 |
Public-firm execs get $116,000 p545 B. J. Spalding doi:10.1038/nbt0593-545 PDF
(116K)
|
 |
 |
 |
First quarter sees 27 firms raise $649.7 million p548 B. J. Spalding doi:10.1038/nbt0593-548 PDF
(105K)
|
 |
 |
 |
Shaman's $45 million IPO is quarter's biggest p549 Mark Goodstein doi:10.1038/nbt0593-549a PDF
(122K)
|
 |
 |
 |
Latvian biotech firm busted for selling speed p549 Gerard O'Dwyer doi:10.1038/nbt0593-549b PDF
(122K)
|
 |
 |
 |
European trade associations move to consolidate p551 Mike Ward doi:10.1038/nbt0593-551 PDF
(126K)
|
 |
 |
 |
Improved animal feed may be just "chicken feed" p552 George Kidd doi:10.1038/nbt0593-552 PDF
(131K)
|
 |
 |
 |
15 agbiotech firms lost $126.4 million last year p554 B. J. Spalding doi:10.1038/nbt0593-554a PDF
(88K)
|
 |
 |
 |
FDA advisory panel mooooves Monsanto's BST pp554 - 555 Jeffrey L. Fox doi:10.1038/nbt0593-554b PDF
(202K)
|
 |
 |
 |
CLIA '88 lab regulations are watered down p556 Joseph Alper doi:10.1038/nbt0593-556 PDF
(242K)
|
 |
 |
 |
Vague shape of Clinton's biotech policy emerges pp558 - 559 Russ Hoyle doi:10.1038/nbt0593-558 PDF
(277K)
|
 |
| Articles | Top |
 |
 |
 |
Multiuse Biopharmaceutical Manufacturing pp561 - 570 Mic N. Hamers doi:10.1038/nbt0593-561 Abstract + references | PDF
(833K)
|
 |
 |
 |
Flow Cytometry in Animal Cell Culture pp572 - 579 Mohamed Al-Rubeai
& A. Nicholas Emery doi:10.1038/nbt0593-572 Abstract + references | PDF
(612K)
|
 |
 |
 |
Nuclease Therapeutics in the Clinic pp580 - 582 Stephen M. Edgington doi:10.1038/nbt0593-580 Abstract + references | PDF
(359K)
|
 |
| Review | Top |
 |
 |
 |
Molecular Analysis of Small Grain Cereal Genomes: Current Status and Prospects pp584 - 589 Graham Moore, Michael D. Gale, Nori Kurata
& Richard B. Flavell doi:10.1038/nbt0593-584 Abstract + references | PDF
(813K)
|
 |
| Research | Top |
 |
 |
 |
Efficient Production of Antibody Fragments by the Filamentous Fungus Trichoderma reesei pp591 - 595 Eini Nyyssönen, Merja Penttilä, Anu Harkki, Anu Saloheimo, Jonathan K. C. Knowles
& Sirkka Keränen doi:10.1038/nbt0593-591 Abstract + references | PDF
(815K)
|
 |
 |
 |
Transformation of Elite Cotton Cultivars via Particle Bombardment of Meristems pp596 - 598 Dennis E. McCabe
& Brian J. Martinell doi:10.1038/nbt0593-596 Abstract + references | PDF
(459K)
|
 |
 |
 |
Recombinant Colorimetric Antibodies: Construction and Characterization of a Bifunctional F(ab)2/Alkaline Phosphatase Conjugate Produced in Escherichia coli pp601 - 605 Frédéric Ducancel, Daniel Gillet, Alice Carrier, Evelyne Lajeunesse, André Ménez
& Jean-Claude Boulain doi:10.1038/nbt0593-601 Abstract + references | PDF
(869K)
|
 |
 |
 |
Conversion of Starch to Ethanol in a Recombinant Saccharomyces cerevisiae Strain Expressing Rice -Amylase from a Novel Pichia pastoris Alcohol Oxidase Promoter pp606 - 610 Monto H. Kumagai, Genadie G. Sverlow, Guy della-Cioppa
& Laurence K. Grill doi:10.1038/nbt0593-606 Abstract + references | PDF
(963K)
|
 |
 |
 |
Efficient Bacterial Export of a Eukaryotic Cytoplasmic Cytochrome pp612 - 618 Amna Karim, Naheed Kaderbhai, Alun Evans, Victoria Harding
& Mustak A. Kaderbhai doi:10.1038/nbt0593-612 Abstract + references | PDF
(1,284K)
|
 |
| Book Review | Top |
 |
 |
 |
The Driving Forces of Biotechnology pp620 - 621 Jan A. Witkowski doi:10.1038/nbt0593-620 PDF
(363K)
|
 |
| Biotools | Top |
 |
 |
 |
BioBOSS: A Bioprocessing Software Tool pp622 - 623 Terhi Siimes, Marjut Pokkinen, Andrea Holmberg
& Pekka Linko doi:10.1038/nbt0593-622 References | PDF
(325K)
|
 |
 |
 |
Ribozymes' Patent History pp624 - 625 Stephen M. Edgington doi:10.1038/nbt0593-624 PDF
(360K)
|
 |
| Bio Q&A | Top |
 |
 |
 |
Fermentation and Cell Culture p626 John Hodgson doi:10.1038/nbt0593-626 PDF
(101K)
|
 |
| Fermentors | Top |
 |
 |
 |
Fermentors p628 doi:10.1038/nbt0593-628 PDF
(168K)
|
 |
| Reader Service | Top |
 |
 |
 |
| New Products |
 |
 |
 |
New Products pp629 - 630 doi:10.1038/nbt0593-629 PDF
(290K)
|
 |
| The Last Word | Top |
 |
 |
 |
A Word or Two from the Wise p636 John Hodgson doi:10.1038/nbt0593-636 PDF
(101K)
|
 |
Top |
 |
 |